Search results for "Psychotic"

showing 10 items of 360 documents

Consumo de substancias durante el embarazo y dimensiones de personalidad

2020

Este estudio evalúa los patrones de consumo de substancias durante el embarazo y las dimensiones de personalidad asociadas, en una muestra multicéntrica de 1804 mujeres de población general. En el 2-3 día posparto, completaron una entrevista auto-administrada sobre el consumo de alcohol, tabaco, cafeína, cannabis, cocaína, opiáceos, drogas de diseño, además de variables socio-demográficas, obstétricas/reproductivas, historia psiquiátrica previa, apoyo social durante el embarazo y el cuestionario de personalidad de Eysenck (EPQ-RS). Se generaron modelos de regresión logística múltiple. La prevalencia del consumo fue del 50% (N=909): 40% cafeína, 21% tabaco, 3,5% alcohol, y 0,3 cannabis. Las …

Embarazomedia_common.quotation_subject030508 substance abuseMedicine (miscellaneous)03 medical and health sciencesSocial supportPsychiatric historyPsychoticismmedicinePersonalityPersonalidadmedia_commonCannabisPregnancyExtraversion and introversionbusiness.industryEstadística matemàtica--AplicacionsConsumo de substancias:62 Statistics::62P Applications [Classificació AMS]medicine.diseaseNeuroticismEysenck Personality QuestionnairePsychiatry and Mental healthMathematical statisticsCafeínaTabaco:Matemàtiques i estadística::Estadística matemàtica [Àrees temàtiques de la UPC]0305 other medical sciencebusinessAlcoholClinical psychology
researchProduct

Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia

2022

The EU-GEI Project was funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI). The Brazilian study was funded by the Säo Paulo Research Foundation under grant number 2012/0417-0.

Emotions1ST-EPISODE SCHIZOPHRENIADEFICITSfacial affect recognition genetic liability first episode psychosisfirst episode psychosisSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansCLINICAL HIGH-RISKSettore MED/25 - PsichiatriaPsychiatric Status Rating ScalesDepressive Disorder MajorARCHITECTUREPERCEPTIONIDENTIFICATIONUNAFFECTED SIBLINGSBIPOLAR DISORDERFacial ExpressionINDIVIDUALSPsychiatry and Mental healthPsychotic Disordersfacial affect recognitionCase-Control StudiesRELIABILITYSchizophreniaFacial Recognitiongenetic liabilitySchizophrenia bulletin
researchProduct

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.

2021

Introduction The aim of this study was to describe the number and type of drugs used to treat depressive disorders in inpatient psychiatry and to analyse the determinants of potential drug-drug interactions (pDDI) and potentially inappropriate medication (PIM). Methods Our study was part of a larger pharmacovigilance project funded by the German Innovation Funds. It included all inpatients with a main diagnosis in the group of depressive episodes (F32, ICD-10) or recurrent depressive disorders (F33) discharged from eight psychiatric hospitals in Germany between 1 October 2017 and 30 September 2018 or between 1 January and 31 December 2019. Results The study included 14,418 inpatient cases.…

Epidemiologymedicine.medical_treatment0302 clinical medicineRisk FactorsMedicine and Health SciencesAntipsychoticsDrug Interactions030212 general & internal medicineDepression (differential diagnoses)Potentially Inappropriate Medication Listmedia_commonMultidisciplinaryDepressionPharmaceuticsQRDrugsAntidepressantsMiddle AgedAntidepressive AgentsAntidepressant Drug TherapyMedicineAntidepressantDrug Therapy CombinationAntipsychotic AgentsResearch ArticleDrugNeurological Drug Therapymedicine.medical_specialtyPatientsSciencemedia_common.quotation_subject03 medical and health sciencesPharmacotherapyDrug TherapyInternal medicinePharmacovigilanceMental Health and PsychiatrymedicineHumansAntipsychoticProbabilityPolypharmacyPharmacologyInpatientsbusiness.industryMood DisordersOdds ratioHealth CareLogistic ModelsMedical Risk Factorsbusiness030217 neurology & neurosurgeryReceptor Antagonist TherapyPloS one
researchProduct

Personality and movie preferences: A comparison of American and German audiences

1993

Abstract The impact of personality type (extraversion, neuroticism, psychoticism) and culture (American, German) on preferences for contemporary movies was explored. Consistent with theoretical expectations, the findings revealed that movie preferences were mediated by both the psychoticism and extraversion personality types and by an interaction between psychoticism by culture.

Extraversion and introversionmedia_common.quotation_subjectNeuroticismlanguage.human_languageDevelopmental psychologyGermanTrait theoryPersonality typePsychoticismlanguagePersonalityBig Five personality traitsPsychologySocial psychologyGeneral Psychologymedia_commonPersonality and Individual Differences
researchProduct

Retrospective Experiences of First-Episode Psychosis Treatment Under Open Dialogue-Based Services: A Qualitative Study.

2021

AbstractOpen Dialogue (OD) is an integrated approach to mental health care, which has demonstrated promising outcomes in the treatment of first-episode psychosis (FEP) in Finnish Western Lapland region. However, little is known how treatment under OD is retrospectively experienced by the service users themselves. To address this, twenty participants from the original Western Lapland research cohort diagnosed with psychosis (F20–F29) were asked about their treatment of FEP, initiated under OD 10–23 years previously. Thematic analysis was used to explore how the treatment was experienced. Most participants viewed network treatment meetings as an important part of their treatment, as they enab…

Family therapymedicine.medical_specialtyPsychosisHealth (social science)long-term follow-upCohort StudiesFirst episode psychosisdialogisuusmedicineHumansPsychiatryQualitative ResearchRetrospective Studiesskitsofreniapsykoositfirst person accountsPublic Health Environmental and Occupational Healthneed-adapted approachperheterapiaIntegrated approachmielenterveystyömedicine.diseaseschizophreniaPsychiatry and Mental healthPsychotic DisordersSchizophreniaCohortkokemuksetfamily therapyseurantatutkimusThematic analysisPsychologyQualitative researchCommunity mental health journal
researchProduct

A History of the Pharmacological Treatment of Bipolar Disorder.

2018

In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agents introduced in the 19th and early 20th century, such as solanaceae alkaloids, bromides and barbiturates, to John Cade’s experiments with lithium and the beginning of the so-called “Psychopharmacological Revolution” in the 1950s. We also describe the clinical studies and development processes, enabling the therapeutic introduction of pharmacological agents currently available for the treatment of bipolar disorder in its different phases and manifestations. Those drugs include lithium salts, valproic acid, carbamazepine, new antiepilep…

Farmacología veterinariamedicine.drug_classPsychopharmacologyFarmacologíaantipsychotic drugsAtypical antipsychoticCariprazineReviewPharmacologyLamotrigineLithiumHistory 21st CenturyCatalysisTreatment of bipolar disorderInorganic Chemistrylcsh:Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinepharmacological treatmentmedicineAsenapineAnimalsHumansZiprasidoneantiepileptic drugsPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyPsiquiatríaLurasidonebipolar disorderbusiness.industrymood stabilizer drugsOrganic ChemistryHistory 19th CenturyGeneral MedicineHistory 20th Century030227 psychiatryComputer Science ApplicationsTranquilizing Agentschemistrylcsh:Biology (General)lcsh:QD1-999Quetiapinebusiness030217 neurology & neurosurgerymedicine.drug
researchProduct

Hospitalisation and length of hospital stay following first-episode psychosis:Systematic review and meta-analysis of longitudinal studies

2019

AbstractBackgroundReducing hospitalisation and length of stay (LOS) in hospital following first episode psychosis (FEP) is important, yet reliable measures of these outcomes and their moderators are lacking. We conducted a systematic review and meta-analysis to investigate the proportion of FEP cases who were hospitalised after their first contact with services and the LOS in a hospital during follow-up.MethodsStudies were identified from a systematic search across major electronic databases from inception to October 2017. Random effects meta-analyses and meta-regression analyses were conducted.Results81 longitudinal studies encompassing data for 23 280 FEP patients with an average follow-u…

First contactAdultMalePediatricsmedicine.medical_specialtyFirst episode psychosisAsiaTime FactorsAdolescentUntreated psychosisinpatient03 medical and health sciencesYoung Adult0302 clinical medicinelength of stayFirst episode psychosismedicinefollow-upHumansLongitudinal StudiesApplied Psychologybusiness.industryhospitalisationAustraliaLength of Staymedicine.disease030227 psychiatryEuropeHospitalizationschizophreniaPsychiatry and Mental healthPsychotic DisordersSchizophreniaMeta-analysisNorth AmericaSchizophreniaoutcomeFemalebusinessHospital stay030217 neurology & neurosurgerySystematic searchNew Zealand
researchProduct

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates.

2004

Abstract The pharmacokinetics of antipsychotic drugs has become an integral part in understanding their pharmacodynamic activity and clinical effects. In addition to metabolism aspects, carrier-mediated transport, particularly secretion by ABC transporters, has been discussed as potentially relevant for this group of therapeutics. In this study, the psychoactive compounds perphenazine, flupentixol, domperidone, desmethyl clozapine, haloperidol, fluphenazine, fluvoxamine, olanzapine, levome-promazine, perazine, desmethyl perazine, clozapine, quetiapine and amisulpride were characterized in terms of P-glycoprotein (P-gp) affinity and transport. Experimental methods involved a radioligand disp…

FluphenazineMalePerphenazineATP Binding Cassette Transporter Subfamily BPharmaceutical SciencePharmacologySubstrate Specificitychemistry.chemical_compoundPharmacokineticsmedicineFluphenazineAnimalsHumansDrug InteractionsTissue DistributionAmisulprideClozapinePharmacologyBrainPerazineFlupentixolRatschemistryCyclosporineAmisulprideCaco-2 CellsSulpirideImmunosuppressive Agentsmedicine.drugTalinololAntipsychotic AgentsThe Journal of pharmacy and pharmacology
researchProduct

Antidepressants and Antipsychotic Drugs Colocalize with 5-HT(3) Receptors in Raft-Like Domains

2005

Despite different chemical structure and pharmacodynamic signaling pathways, a variety of antidepressants and antipsychotics inhibit ion fluxes through 5-HT3receptors in a noncompetitive manner with the exception of the known competitive antagonists mirtazapine and clozapine. To further investigate the mechanisms underlying the noncompetitive inhibition of the serotonin-evoked cation current, we quantified the concentrations of different types of antidepressants and antipsychotics in fractions of sucrose flotation gradients isolated from HEK293 (human embryonic kidney 293) cells stably transfected with the 5-HT3Areceptor and of N1E-115 neuroblastoma cells in relation to the localization of …

Fluphenazinemedicine.medical_specialtyPharmacology5-HT3 receptorCell LineMembrane MicrodomainsDesipramineInternal medicinemedicineHumansSerotonin 5-HT3 Receptor AntagonistsReceptorClozapine5-HT receptorbiologyChemistryGeneral NeuroscienceAntidepressive AgentsEndocrinologybiology.proteinSerotoninSerotonin AntagonistsSignal transductionReceptors Serotonin 5-HT3medicine.drugCellular/MolecularAntipsychotic AgentsProtein Binding
researchProduct

Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy

2018

Background For many years, long-acting intramuscular (LAI) antipsychotics have been prescribed predominantly to chronic and severe patients, as a last resort when other treatments failed. Recently, a broader and earlier use of LAIs, particularly second-generation LAIs, has been emphasized. To date, few studies attempted to frame how this change in prescribing took place in real-world practice. Therefore, this study aimed to describe the clinical features of patients prescribed with LAIs, and to explore possible prescribing differences between first- and second-generations LAIs under ordinary clinical practice in Italy. Methods The STAR Network "Depot" Study is an observational, longitudinal…

Genetics and Molecular Biology (all)MalePediatricsEuropean PeopleBipolar DisorderCross-sectional studyEconomicsEpidemiologymedicine.medical_treatmentassessmentviruseslcsh:MedicineSocial SciencesLongitudinal StudieBiochemistryPrescriptionGeographical locations0302 clinical medicineMathematical and Statistical TechniquesBiochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)immune system diseasesEpidemiologyMedicine and Health Scienceslong-acting intramuscular (LAI) antipsychotics; clinical practice; assessment; second-generation antipsychotic (SGA) LAIsAntipsychoticsEthnicitiesLongitudinal Studieslcsh:ScienceMultidisciplinaryvirus diseasesDrugsMiddle Agedclinical practiceItalian PeopleEuropePrescriptionsItalyPhysical SciencesAripiprazoleFemaleBivariate AnalysisStatistics (Mathematics)medicine.drugHumanResearch ArticleAntipsychotic AgentsEmploymentAdultmedicine.medical_specialtyAdolescentResearch and Analysis Methods03 medical and health sciencesMental Health and PsychiatrymedicineHumansPaliperidoneBipolar disorderEuropean UnionStatistical MethodsAntipsychoticCross-Sectional StudiePharmacologyRisperidoneBiochemistry Genetics and Molecular Biology (all)business.industryMood Disorderslcsh:Rmedicine.disease030227 psychiatryAntipsychotic AgentCross-Sectional StudiesAgricultural and Biological Sciences (all)Labor EconomicsMultivariate AnalysisSchizophreniaObservational studylcsh:QPopulation Groupingslong-acting intramuscular (LAI) antipsychoticsPeople and placesbusiness030217 neurology & neurosurgerysecond-generation antipsychotic (SGA) LAIsMathematicsPLoS ONE
researchProduct